4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001841401-26-000007
General Counsel sold 12,440 shares at an average $68.36 ($850,417)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wahl Bryan General Counsel | 2026-03-17 | Sale | −4,084 | $69.42 | $283,511 | 72,315 | D |
| Wahl Bryan General Counsel | 2026-03-18 | Sale | −4,125 | $68.71 | $283,429 | 68,190 | D |
| Wahl Bryan General Counsel | 2026-03-19 | Sale | −4,231 | $67.00 | $283,477 | 63,959 | D |
| Open-market sales · 12,440 sh · avg $68.36 · $850,417 | |||||||
Loading xslF345X06/wk-form4_1773961481.xml…